Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NIO✓SelectedUSD · NIOGSK vs NIO performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs NIO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+80.4%
NIO return
-53.2%
Excess return
+133.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioNIOExcessAlpha
1D-2.3%+3.3%-5.6%-2.4%
7D-3.0%-14.3%+11.3%-2.7%
30D+0.4%-18.1%+18.4%+0.8%
3M-1.2%-38.9%+37.7%-0.1%
6M+0.9%-53.9%+54.9%+2.7%
YTD+4.0%-44.9%+48.9%+5.2%
1Y+7.3%-53.8%+61.1%+8.9%
3Y+57.1%-62.0%+119.0%+58.5%
5Y+43.0%-92.9%+135.9%+47.3%
All+80.4%-53.2%+133.6%+75.7%

Cumulative growth

Daily Returns

Daily percentage return beside NIO.

Daily Out/Under-Performance

Portfolio return minus NIO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded NIO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling